Biocure Technology Inc.
BICTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.07 | -0.01 | 0.01 | -0.14 |
| FCF Yield | -1.81% | -31.57% | -58.37% | -0.00% |
| EV / EBITDA | -5.20 | -9.35 | -16.58 | -202.10 |
| Quality | ||||
| ROIC | -2.67% | -1.21% | -0.30% | -14.20% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.09 | 2.43 | 1.95 | 0.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 94.43% | -324.91% | -138,995.96% | 99.60% |
| Safety | ||||
| Net Debt / EBITDA | -0.15 | -0.02 | -11.38 | -0.15 |
| Interest Coverage | -18.96 | -4.76 | -1.98 | -56.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |